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A commentary on
The dopamine and cannabinoid interac-
tion in the modulation of emotions and 
cognition: assessing the role of cannabi-
noid CB1 receptor in neurons expressing 
dopamine D1 receptors
by Terzian, A., Drago, F., Wotjak, C. T., and 
Micale, V. (2011). Front. Behav. Neurosci. 
5:49. doi: 10.3389/fnbeh.2011.00049
The contribution of dopamine and can-
nabinoid neurotransmission in emotional 
brain circuits regulating motivational and 
emotional neural processing has been well 
acknowledged by both animal and clini-
cal studies (LeDoux, 2000; Laviolette and 
Grace, 2006). The endocannabinoid system 
has arisen as part of the complex circuitry 
that regulates stress and as a crucial media-
tor of emotional learning (for a comprehen-
sive review see Viveros et al., 2005). The idea 
that this system is involved in the control of 
emotions is rooted in the fact that Cannabis 
sativa is used recreationally, mainly for its 
euphoric effects. The dopamine (DA) neu-
rotransmitter system is significantly crucial 
for the neural processing of motivational 
and emotionally salient information (Wise, 
2004). Yet, less is known about the func-
tional interaction between cannabinoid 
and dopaminergic receptors in the con-
trol of emotional behavior. Much of our 
understanding has been improved only 
recently by studies using knockout (KO) 
animals (Micale et al., 2009; Ortega-Alvaro 
et al., 2011; Thanos et al., 2011), behav-
ioral approaches (Ramiro-Fuentes and 
Fernandez-Espejo, 2011; Zarrindast et al., 
2011), or neuroanatomical and electro-
physiological techniques (Chiu et al., 2010).
In an intriguing article of the Special 
Issue “The endocannabinoid system: a 
key modulator of emotions and cogni-
tion” published in Frontiers in Behavioral 
Neuroscience, Terzian and colleagues pro-
vide the first evidence for a physiological 
cross-talk between the cannabinoid CB1 
receptors (CB1Rs) and the dopamine D1 
receptors (D1Rs) in the modulation of 
depression-like behavior, social skills, and 
fear conditioning. Specifically, these authors 
examined the responses of conditional CB1 
mutant mice genetically selected for the 
absence of CB1Rs exclusively in neurons 
containing D1Rs receptors (D1–CB1 KO 
mice), in a battery of behavioral tests, and 
reported the following interesting results. 
First, when compared to their WT coun-
terparts, D1–CB1 KO mice displayed simi-
lar performance in the social novelty, the 
elevated plus maze, and the light/dark test 
(all paradigms evaluating different aspects 
of unconditioned anxiety), but spent more 
time on grooming activity and showed less 
social interaction when tested under low 
aversive conditions. By measuring the anxi-
ety-like profile of these animals using differ-
ent tests, authors thus disentangled different 
components of the anxiety state, bringing 
to light the specific role of CB1–D1 recep-
tors in modulating emotional states under 
conditions of stress-induced conflict/frus-
tration (grooming behavior) or inescapable 
situations (social interactions). Secondly, 
D1–CB1 KO mice showed lower sucrose 
consumption than WT mice, a behavior 
reminiscent of a mild anhedonia-like state 
(commonly associated with depression). 
However, the finding that such a difference 
disappears on the second day of testing does 
not support a depressive-like behavioral 
phenotype, as also suggested by the observa-
tion that KO mice performed as WTs in the 
forced swim test (commonly used to evalu-
ate animals’ behavioral despair). Finally, in 
the fear conditioning task (a fear-related 
memory test involving a strong mnemonic 
component), D1–CB1 KO mice showed 
significantly increased auditory-cued and 
contextual fear responses, which is not 
surprising when considering the impor-
tant role of DA receptors in fear adapta-
tion processes (El-Ghundi et al., 2001; de la 
Mora et al., 2010) and that of CB1 receptors 
in fear alleviation (Marsicano et al., 2002; 
Kamprath et al., 2006).
The main outcome of this study is the 
demonstration that CB1Rs and D1Rs coop-
erate for the control of a negative affect. 
This implies that D1R and CB1R signaling 
systems may mediate overlapping pharma-
cological responses in clinically important 
brain areas that mediate diseases, such as 
Parkinson and epilepsy, in which these two 
classes of receptors have been reported 
to strictly interact (Ferrer et al., 2003; 
Gangarossa et al., 2011).
Although limited by potential compen-
satory mechanisms that may take place dur-
ing development, these conditional animals 
represent a precious tool for investigating 
whether CB1 and D1 receptors also interact 
in modulating other brain circuits (motiva-
tion, reward) and behavioral traits (impul-
sivity/compulsivity), which may contribute 
to the development of several disorders (i.e., 
binge eating disorder). The involvement of 
the two receptor systems in motivational 
and emotional neural processing phenom-
ena also suggests that their interaction 
might be implicated in other neuropathol-
ogies such as schizophrenia and addiction 
(Grace, 1995, 2000; Zavitsanou et al., 2004; 
Semple et al., 2005).
Perhaps the most robust effect demon-
strated by Terzian and colleagues involves 
the enhancement of conditioned fear and 
the possible attenuation of extinction learn-
ing. This is an important step in advancing 
our knowledge on the functional interac-
tion between D1Rs and CB1Rs in emo-
tional neural processing and specifically 
fear adaptation. However, further studies 
are required to clarify the mechanisms 
underlying cannabinoids modulation of 
the DAergic system. For example, it needs 
to be determined what are the specific neu-
ronal circuits mediating the effects on fear 
retrieval and fear adaptation in the D1–CB1 
KO mice. Another issue to focus on is short- 
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mice. The ability to extinguish emotional 
responses in the face of a no-longer rel-
evant conditioned cue is an essential part 
of a healthy emotional memory system 
(Charney et al., 1993) and deficits in fear 
extinction are thought to contribute to anx-
iety disorders such as post-traumatic stress 
disorder (PTSD). It has been consistently 
demonstrated that CB1R-deficient mice and 
CB1R antagonists block fear extinction. The 
results by Terzian et al. (2011) suggest that 
this may also be the case with the D1–CB1 
KO mice. This should be carefully exam-
ined as it is a clinically relevant issue to ask 
whether or not a stimulation of D1R–CB1R 
signaling might accelerate extinction of fear 
and hence, might be therapeutically effec-
tive in the treatment of anxiety disorders, 
particularly PTSD.
In conclusion, findings here reported by 
Terzian and colleagues represent an appeal-
ing topic of investigation from both phar-
macological and pharmaceutical points of 
view in that it provides a rationale of devel-
oping in the future chemical compounds 
that, by manipulating simultaneously both 
the D1Rs and CB1Rs, may ameliorate nega-
tive and aversive emotional states.
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